All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
GWP / GW Pharmaceuticals plc
|
|
|
|
|
|
|
|
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
PDSB / PDS Biotechnology Corporation
|
|
|
|
|
|
|
|
PCRX / Pacira BioSciences, Inc.
|
|
|
|
|
|
|
|
OMED / OptMed Inc
|
|
|
|
|
|
|
|
EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ARQL / ArQule, Inc.
|
|
|
|
|
|
|
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
ETTX / Entasis Therapeutics Holdings Inc
|
|
|
|
|
|
|
|
ICPT / Intercept Pharmaceuticals Inc
|
|
|
|
|
|
|
|
CNAT / Conatus Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
ITRM / Iterum Therapeutics plc
|
|
|
|
|
|
|
|
TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
BOLD / Boundless Bio, Inc.
|
|
|
|
|
|
|
|
OSMT / Osmotica Pharmaceuticals Plc
|
|
|
|
|
|
|
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
OCGN / Ocugen, Inc.
|
|
|
|
|
|
|
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
OBSV / ObsEva SA.
|
|
|
|
|
|
|
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
ONCE / Spark Therapeutics, Inc.
|
|
|
|
|
|
|
|
KDMN / Kadmon Holdings Inc
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
MOLN / Molecular Partners AG
|
|
|
|
|
|
|
|
ESPR / Esperion Therapeutics, Inc.
|
|
|
|
|
|
|
|
H03579101 / Auris Medical Holding Ltd
|
|
|
|
|
|
|
|
ADMS / Adamas Pharmaceuticals Inc
|
|
|
|
|
|
|
|
MOR / MorphoSys AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
FSTX / F-star Therapeutics Inc
|
|
|
|
|
|
|
|
PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
US74257L1089 / Principia Biopharma Inc.
|
|
|
|
|
|
|
|
US16706W1027 / Chiasma Inc
|
|
|
|
|
|
|
|
0HBB / Aimmune Therapeutics Inc
|
|
|
|
|
|
|
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
14161H108 / Cardtronics PLC
|
|
|
|
|
|
|
|
DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
CLSD / Clearside Biomedical, Inc.
|
|
|
|
|
|
|
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
MRUS / Merus N.V.
|
|
|
|
|
|
|
|
OTIC / Otonomy Inc
|
|
|
|
|
|
|
|
FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
018490100 / Allergan plc
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
INCY / Incyte Corporation
|
|
|
|
|
|
|
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SNY / Sanofi - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
KALA / KALA BIO, Inc.
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
KDNY / Chinook Therapeutics Inc
|
|
|
|
|
|
|
|
EXEL / Exelixis, Inc.
|
|
|
|
|
|
|
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
|
|
|
|
|
RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
|
|
|
|
|
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock) Call
|
|
|
|
|
|
|
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
YMAB / Y-mAbs Therapeutics, Inc.
|
|
|
|
|
|
|
|
IMGN / ImmunoGen, Inc.
|
|
|
|
|
|
|
|
NCNA / NuCana plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SVRA / Savara Inc.
|
|
|
|
|
|
|
|
ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
SYBX / Synlogic, Inc.
|
|
|
|
|
|
|
|
FGEN / FibroGen, Inc.
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|